Lotus Biochem
F·43Storefront went dark in spring 2026; the slot is preserved so older outbound links resolve cleanly.
Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.
- Testing methods
- Not publicly disclosed.
- Testing lab
- Not publicly disclosed.
- Most recent COA
- Not publicly posted.
- OpenAssay score ↗
- — pending integration with openassay.org.
- Testing transparency13/40
Public 7-category testing rubric grade plus disclosed testing methods plus a named third-party lab. The full range is gated on the vendor publicly naming the tests they run; a high rubric grade without disclosure caps at 18 of 40.
- Operational & regulatory standing0/25
Reflects FDA actions, payment-processor issues, ownership uncertainty, closures, and editorial audit notes the vendor-risk monitor has surfaced. A recent published COA earns a small bonus on top of the operational base.
- Operational stability12/15
Vendor age. 5+ years of operation earns full points; 1 year or less earns minimal credit. Absent foundedYear earns a neutral default; absence of data is not proof of risk.
- Verification tier10/10
Editorial tier assignment based on documentation completeness, response to corrections, and presence of verifiable business address. Tier 1 vendors meet the highest bar.
- Price discipline8/10
Heuristic check on aggressive discounting. Reasonable codes (<=25%) earn full points; 25-40% earns half; >40% off list often signals inventory clearance or churn and earns zero.
- The lotusbiochem.com storefront has been unreachable since spring 2026.
- Similarly named brands (lotuspeptide.com, lotilabs.com, lotuspeptides.com) are distinct businesses; do not conflate.
Editorial observations recorded during our vendor review. Send corrections to corrections@pepticker.com.
- ✓Identity verified
- ✓Net content confirmed
- ✓Net purity ≥ 97%
- ✓Endotoxin tested
- ✓Sterility tested
- ·Heavy metals screened
- ·Conformity documented
Our vendor-risk monitor tracks closures, payment-processor issues, FDA actions, and community sentiment.
Tracked SKUs
15 listings| Peptide | Size | Price | $/mg | Status |
|---|---|---|---|---|
| BPC-157 | 5mg | $34.50 | $6.90 | In stock |
| BPC-157 | 10mg | $59.50 On sale | $5.95 | In stock |
| CJC-1295 + Ipamorelin Blend | 10mg | $72.50 On sale | $7.25 | In stock |
| Epitalon | 10mg | $41.50 | $4.15 | In stock |
| GHK-Cu | 50mg | $29.50 | $0.59 | In stock |
| MOTS-c | 10mg | $84.50 | $8.45 | In stock |
| PT-141 | 10mg | $46.50 | $4.65 | In stock |
| Retatrutide | 5mg | $109.50 | $21.90 | In stock |
| Retatrutide | 10mg | $205.50 | $20.55 | In stock |
| Semaglutide | 5mg | $56.50 | $11.30 | In stock |
| Semaglutide | 10mg | $92.50 | $9.25 | In stock |
| TB-500 | 5mg | $44.50 On sale | $8.90 | In stock |
| TB-500 | 10mg | $82.50 | $8.25 | In stock |
| Tirzepatide | 10mg | $135.50 | $13.55 | In stock |
| Tirzepatide | 30mg | $309.50 | $10.32 | In stock |
More on Lotus Biochem & similar vendors
- BPC-157— Tissue-repair research peptide
- TB-500— Actin-binding healing fragment
- Semaglutide— GLP-1 agonist for metabolic research
- Tirzepatide— Dual GLP-1/GIP agonist
- Retatrutide— Triple GCG/GIP/GLP-1 agonist
- BioLongevity Labs— Tier 1 · score 6.0/7
- Core Peptides— Tier 1 · score 6.5/7
- Ascension Peptides— Tier 1 · score 5.5/7